CSI Market
Sign In | Register

Ambrx Biopharma Inc (AMAM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AMAM Annual Balance Sheets →
Tracking balance sheet results across Ambrx Biopharma Inc to Jun 30 2022 helps illustrate how Sep 30 2023's financial position has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Jun 30 2022)
Assets
Cash & cash equivalent225.26
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments225.00
Accounts receivable0.12
Notes Receivable, Current0.00
Other Current Assets0.67
Prepaid Expense And Other Assets Current7.77
Total Current Assets233.82
Equipment/Property/Plant Net3.00
Intangible Assets24.78
Long-term investments0.00
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent3.00
Restricted Cash Current0.67
Operating Lease Right Of Use Asset9.57
Total Assets271.50
Liabilities
Accounts Payable, Current AC5.14
Accrued Liabilities, Current AC10.81
Other Liabilities, Current1.92
Taxes Payable0.00
Deferred Revenue, Current DE0.41
Total Current Liabilities18.27
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE1.34
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent9.49
Operating Lease Liability Current1.92
Operating Lease Liability Noncurrent8.61
Deferred Income Tax Liabilities Net0.88
Deferred Income Tax Liabilities Net0.00
Total Liabilities29.10
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock590.93
Retained Earnings / Accumulated Deficit-347.75
Accumulated Other Comprehensive Income0.00
Other Equity-0.79
Common Stockholder's Equity242.40
Total Stockholder's Equity242.40
Liabilities & Stockholder's Equity271.50
4 historic quarters locked

Sign in to unlock the full Ambrx Biopharma Inc balance sheet history.

Sign In Create Free Account

About Ambrx Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-062916

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.